Amanda Storjohann

Title: Inventor Amanda Storjohann: A Pioneer in Nicotinoyl Riboside Research

Introduction

Amanda Storjohann, an innovative inventor based in Westminster, Colorado, has made significant contributions to the field of biochemistry with her work focusing on nicotinoyl ribosides. With a remarkable portfolio of eight patents, she has played a crucial role in advancing the methodologies related to these compounds.

Latest Patents

Among her latest patents are two notable disclosures that detail efficient and scalable syntheses of nicotinoyl ribosides and their reduced derivatives. These patents describe methods for creating various analogs and conjugates, which include phosphorylated variants and adenylyl dinucleotide conjugates. Her work on novel crystalline forms of these compounds ensures that her contributions are not only theoretical but also practical for potential applications in pharmaceutical research.

Career Highlights

Amanda's professional journey includes significant stints at Chromadex Inc. and The Queen's University of Belfast. Her experiences at these institutions have enriched her knowledge and expertise in the field, fostering her innovative spirit and enhancing her capability to develop new compounds.

Collaborations

Throughout her career, Amanda has collaborated with esteemed colleagues, including Philip Redpath and Aron Erickson. These partnerships have likely contributed to her success and have helped drive forward the research in her areas of expertise.

Conclusion

In summary, Amanda Storjohann stands out as a talented inventor with a commendable number of patents and significant contributions to the development of nicotinoyl ribosides. Her innovative techniques and collaborative spirit exemplify the dynamic nature of research in the biochemistry field. Through her work, she continues to pave the way for new discoveries that have the potential to impact various industries.